Dctn1 Mutations In Perry Syndrome
Date
2009Author
Farrer, Matthew J.
Hulihan, Mary M.
Kachergus, Jennifer M.
Dächsel, Justus
Stoessl, A. Jon
Grantier, Linda L.
Calne, Susan
Calne, Donald B.
Lechevalier, Bernard
Chapon, Francoise
Tsuboi, Yoshio
Yamada, Tatsuo
Gutmann, Ludwig
Elibol, Bülent
Bhatia, Kailash P.
Wider, Christian W.
Vilariño-Güell, Carles
Ross, Owen A.
Brown, Laura A.
Castanedes-Casey, Monica
Dickson, Dennis W.
Wszolek, Zbigniew K.
xmlui.mirage2.itemSummaryView.MetaData
Show full item recordAbstract
Perry syndrome consists of early-onset parkinsonism, depression, severe weight loss and hypoventilation, in which brain pathology is characterized by TDP-43 immunostaining. Through genome-wide linkage analysis we have identified five disease-segregating dynactin (DCTN1) CAP-Gly domain substitutions in 8 families that diminish microtubule binding and lead to intracytoplasmic inclusions. DCTN1 mutations were previously associated with motor neuron disease but can underlie the selective vulnerability of other neuronal populations in distinct neurodegenerative disorders.
URI
https://doi.org/10.1038/ng.293https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813485/
http://hdl.handle.net/11655/15664